STAT+: FDA warns of security vulnerability in Illumina’s DNA sequencing machines
DNA sequencing machines have typically been designated for “research use only,” but are increasingly used in medical settings to help diagnose disease.
The Food and Drug Administration warned health care providers Thursday that a security vulnerability in DNA sequencers made by Illumina could allow unauthorized users to access or alter potentially important medical data.
The news is an embarrassing development at a time when Illumina’s management team, including CEO Francis deSouza, is trying to fight off a proxy battle by Carl Icahn. The activist investor is seeking to add three new members to Illumina’s board and has said that he would like to remove deSouza as CEO.
What's Your Reaction?
